Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0000950170-25-005630

Chief Commercial Officer bought 43,750 shares at $7.60 ($332,413)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Pinnow Cole Chief Commercial Officer 2025-01-14 Purchase +43,750 $7.60 $332,413 45,848 D
Open-market purchases · 43,750 sh · avg $7.60 · $332,413
Loading xslF345X05/ownership.xml…